Defendants in Olmesartan Cases Seek Creation of Formal Docket in New Jersey State Court



DOCUMENTS
  • Application


TRENTON, N.J. — The makers of blood pressure drugs containing olmesartan medoxomil have asked the New Jersey Supreme Court to create a formal docket for the centralized management of 59 products liability cases in which they have been named as defendants.

In a May 18 motion, Daiichi Sankyo Inc., Daiichi Sankyo U.S. Holdings Inc., Daiichi Sankyo Company Ltd., Forest Laboratories Inc., Forest Pharmaceuticals Inc. and Forest Research Institute Inc. argue that the litigation involves many claims with common, recurrent issues of law and fact, all associated with a similar product.

“Each of the pending cases alleges that treatment with olmesartan …

FIRM NAMES
  • Drinker Biddle & Reath





UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024

MORE DETAILS



HarrisMartin's Webinar Series: Video Game Addiction Product Liability Litigation

March 29, 2024

MORE DETAILS